Emmbi Laboratories Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 06-07-2024
- Paid Up Capital ₹ 6.60 M
as on 06-07-2024
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 1.56%
(FY 2022)
- Ebitda 39.73%
(FY 2022)
- Net Worth 0.51%
(FY 2022)
- Total Assets 0.81%
(FY 2022)
About Emmbi Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.60 M, as per Ministry of Corporate Affairs (MCA) records.
Makrand Moreshwar and Rinku Appalwar serve as directors at the Company.
- CIN/LLPIN
U99999DN1997PTC005657
- Company No.
111985
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Emmbi Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rinku Appalwar  | Director | 12-Nov-1999 | Current |
| Makrand Moreshwar | Director | 12-Jul-1999 | Current |
Financial Performance and Corporate Structure Insights of Emmbi Laboratories.
Emmbi Laboratories Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 1.56% increase in profit. The company's net worth moved up by a moderate rise of 0.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Emmbi Laboratories?
In 2020, Emmbi Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Kitec Industries (India) Private LimitedActive 30 years 10 monthsMakrand Moreshwar and Rinku Appalwar are mutual person
Indian Flexible Intermediate Bulk Container AssociationActive 20 years 9 monthsRinku Appalwar is a mutual person
Emmbi Industries LimitedActive 30 years 22 daysMakrand Moreshwar and Rinku Appalwar are mutual person
- Maithili Agrotech Private LimitedActive 19 years 7 days
Makrand Moreshwar and Rinku Appalwar are mutual person
_PRIVATE_LIMITED.webp)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Emmbi Laboratories?
Unlock and access historical data on people associated with Emmbi Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Emmbi Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Emmbi Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
